A decision by the Egyptian Health Ministry to peg local medicine prices to those of international markets is causing concern, according to IRIN, a service of the UN Office for the Coordination of Humanitarian Affairs.
"This is a catastrophic decision," Karima Al Hefnawy, a member of local non-governmental organization (NGO) the Independent Right to Health Committee, told IRIN. "Egypt is a low-income country, which means that linking local medicine prices with international ones will cause suffering to the poor," he stated.
Only about 30% of Egyptians have health insurance, according to a recent estimate by the NGO. Hitherto, medicine prices were set by the Ministry, sometimes at much lower prices than the manufacturing cost, leading some suppliers to go out of business.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze